N-Acetyl-O-phosphono-Tyr-Glu DipentylamidePhosphopeptide ligand for src SH2 domain CAS# 190078-50-3 |
- Phellodendrine chloride
Catalog No.:BCN5934
CAS No.:104112-82-5
- Lobetyolin
Catalog No.:BCN5894
CAS No.:136085-37-5
- Neferine
Catalog No.:BCN6338
CAS No.:2292-16-2
- Liensinine
Catalog No.:BCN6337
CAS No.:2586-96-1
- Orientin
Catalog No.:BCN4984
CAS No.:28608-75-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 190078-50-3 | SDF | Download SDF |
PubChem ID | 444112 | Appearance | Powder |
Formula | C26H42N3O9P | M.Wt | 571.61 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Sequence | YE (Modifications: Tyr-1 = N-Ac-p-Tyr, Glu-2 = Glu-dipentylamide) | ||
Chemical Name | (4S)-4-[[(2S)-2-acetamido-3-(4-phosphonooxyphenyl)propanoyl]amino]-5-(dipentylamino)-5-oxopentanoic acid | ||
SMILES | CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)C(CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C | ||
Standard InChIKey | LMADZBIAOYLZDD-GOTSBHOMSA-N | ||
Standard InChI | InChI=1S/C26H42N3O9P/c1-4-6-8-16-29(17-9-7-5-2)26(34)22(14-15-24(31)32)28-25(33)23(27-19(3)30)18-20-10-12-21(13-11-20)38-39(35,36)37/h10-13,22-23H,4-9,14-18H2,1-3H3,(H,27,30)(H,28,33)(H,31,32)(H2,35,36,37)/t22-,23-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Phosphopeptide; binds to the src SH2 domain. |
N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide Dilution Calculator
N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide Molarity Calculator
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Firocoxib
Catalog No.:BCC5498
CAS No.:189954-96-9
- Mesopram
Catalog No.:BCC7549
CAS No.:189940-24-7
- Palmitoylisopropylamide
Catalog No.:BCC7187
CAS No.:189939-61-5
- 3-O-Feruloylquinic acid
Catalog No.:BCN3353
CAS No.:1899-29-2
- 8-Amino-2-methylquinoline
Catalog No.:BCC8782
CAS No.:18978-78-4
- Ro 10-5824 dihydrochloride
Catalog No.:BCC7330
CAS No.:189744-94-3
- Akuammiline
Catalog No.:BCN4772
CAS No.:1897-26-3
- 6,4'-Dihydroxy-7-methoxyflavanone
Catalog No.:BCN7797
CAS No.:189689-32-5
- trans-4-phenylbut-3-en-2-one
Catalog No.:BCN3805
CAS No.:1896-62-4
- Dihydrooroxylin A
Catalog No.:BCN3500
CAS No.:18956-18-8
- 6'-Hydroxy-7'-ethoxybergamottin
Catalog No.:BCC8306
CAS No.:
- Pinostrobin chalcone
Catalog No.:BCN1173
CAS No.:18956-15-5
- 7-Hydroxy-2,2-dimethylchromene
Catalog No.:BCN7784
CAS No.:19012-97-6
- Eupatoriochromene
Catalog No.:BCN1174
CAS No.:19013-03-7
- Demethoxyencecalin
Catalog No.:BCN1175
CAS No.:19013-07-1
- Spiratisanin A
Catalog No.:BCN6977
CAS No.:1902173-16-3
- Spiratisanin B
Catalog No.:BCN6976
CAS No.:1902173-19-6
- Spiratisanin C
Catalog No.:BCN6975
CAS No.:1902173-22-1
- Bripiodionene
Catalog No.:BCN1831
CAS No.:190265-70-4
- GR 135531
Catalog No.:BCC6836
CAS No.:190277-13-5
- 7-Hydroxy-4-Methyl-8-Nitrocoumarin
Catalog No.:BCC9210
CAS No.:19037-69-5
- Sarracine N-oxide
Catalog No.:BCN2022
CAS No.:19038-27-8
- 3-Butyryloxytropane
Catalog No.:BCN1924
CAS No.:19038-34-7
- Orientanol A
Catalog No.:BCN4064
CAS No.:190381-82-9
Potent dipeptide inhibitors of the pp60c-src SH2 domain.[Pubmed:9599239]
J Med Chem. 1998 May 21;41(11):1894-908.
The design, synthesis, and evaluation of dipeptide analogues as ligands for the pp60c-src SH2 domain are described. The critical binding interactions between Ac-Tyr-Glu-N(n-C5H11)2 (2) and the protein are established and form the basis for our structure-based drug design efforts. The effects of changes in both the C-terminal (11-27) and N-terminal (51-69) portions of the dipeptide are explored. Analogues with reduced overall charge (92-95) are also investigated. We demonstrate the feasibility of pairing structurally diverse subunits in a modest dipeptide framework with the goal of increasing the druglike attributes without sacrificing binding affinity.
Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.[Pubmed:9174343]
Biochemistry. 1997 May 27;36(21):6283-93.
Thermodynamic measurements, structural determinations, and molecular computations were applied to a series of peptide ligands of the pp60(c-src) SH2 domain in an attempt to understand the critical binding determinants for this class of molecules. Isothermal titration calorimetry (ITC) measurements were combined with structural data derived from X-ray crystallographic studies on 12 peptide-SH2 domain complexes. The peptide ligands studied fall into two general classes: (1) dipeptides of the general framework N-acetylphosphotyrosine (or phosphotyrosine replacement)-Glu or methionine (or S-methylcysteine)-X, where X represents a hydrophobic amine, and (2) tetra- or pentapeptides of the general framework N-acetylphosphotyrosine-Glu-Glu-Ile-X, where X represents either Glu, Gln, or NH2. Dipeptide analogs which featured X as either hexanolamine or heptanolamine were able to pick up new hydrogen bonds involving their hydroxyl groups within a predominantly lipophilic surface cavity. However, due to internal strain as well as the solvent accessibility of the new hydrogen bonds formed, no net increase in binding affinity was observed. Phosphatase-resistant benzylmalonate and alpha,alpha-difluorobenzyl phosphonate analogs of phosphotyrosine retained some binding affinity for the pp60(c-src) SH2 domain but caused local structural perturbations in the phosphotyrosine-binding site. In the case where a reversible covalent thiohemiacetal was formed between a formylated phosphotyrosine analog and the thiol side chain of Cys-188, deltaS was 25.6 cal/(mol K) lower than for the nonformylated phosphotyrosine parent. Normal mode calculations show that the dramatic decrease in entropy observed for the covalent thiohemiacetal complex is due to the inability of the phosphotyrosine moiety to transform lost rotational and translational degrees of freedom into new vibrational modes.